Clinical trials
Completed Cystocele trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 7 |
| Ain Shams Maternity Hospital | 2 |
| Ankara City Hospital Bilkent | 2 |
| Atlantic Health System | 2 |
| Centre Hospitalier Universitaire de Nīmes | 2 |
| Kaiser Permanente | 2 |
| Medstar Health Research Institute | 2 |
| University Hospital, Lille | 2 |
| University of Texas Southwestern Medical Center | 2 |
| pfm medical gmbh | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cystocele | 45 |
| Pelvic Organ Prolapse | 19 |
| Uterine Prolapse | 13 |
| Rectocele | 9 |
| Prolapse | 8 |
| Hernia | 5 |
| Urinary Incontinence | 5 |
| Pelvic Floor Disorders | 3 |
| Urinary Bladder, Overactive | 3 |
| Urinary Incontinence, Stress | 3 |
Trials
Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.